539730
vs
B
BSE Sensex 30
539730
Over the past 12 months, FREDUN has significantly outperformed BSE Sensex 30, delivering a return of +134% compared to the BSE Sensex 30's +10% growth.
Stocks Performance
539730 vs BSE Sensex 30
Performance Gap
539730 vs BSE Sensex 30
Performance By Year
539730 vs BSE Sensex 30
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Fredun Pharmaceuticals Ltd
Glance View
Fredun Pharmaceuticals Ltd. engages in the manufacture and sale of pharmaceuticals, neutraceuticals, herbal and dietary supplements. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2016-03-17. The firm is primarily engaged in the business of pharmaceuticals and healthcare. The company operates through pharmaceutical formulation segment. The company offers a range of products, including antihypertensives, antidiabetic, antiretroviral drugs (ARVs) and narcotics. The company is also engaged in the manufacturing of dietary /herbal supplements, nutraceuticals, and other healthcare products along with animal healthcare products. The firm primarily exports its products to Africa, Southeast Asia, Commonwealth of Independent States (CIS) countries and Latin America.
